Louis W. Sullivan is Director at UNITED THERAPEUTICS CORP (UTHR). They have made 29 open-market trades across 4 companies since 2007, most recently 2026-07-09.
CIK 0001193522
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $44K since 2011, against 27 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MMM | 20,185 | $3.8M |
| UTHR | 2,983 | $1.7M |
| HSIC | 14,096 | $1.2M |
| EBS | 139,098 | $813K |
| BPAX | 47,898 | — |
| INHX | 65,241 | — |
| Total | $7.5M |
Shares reported on the most recent Form 4, priced at the 2026-07-13 close. 2 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL | 2025-12-22 | 2025-12-23 | $512.14 | $6.1M | -2.0% | -8.0% | +1.6% |
| UTHR | SELL | 2024-12-18 | 2024-12-19 | $373.04 | $16.3M | +0.2% | +2.4% | -11.3% |
| UTHR | SELL | 2024-05-03 | 2024-05-06 | $258.39 | $2.7M | +4.1% | +5.9% | +24.6% |
| UTHR | SELL | 2023-03-01 | 2023-03-02 | $245.10 | $172K | -9.9% | -8.0% | -14.4% |
| UTHR | SELL | 2023-02-01 | 2023-02-02 | $261.33 | $183K | -2.3% | -4.3% | -15.8% |
| UTHR | SELL | 2023-01-03 | 2023-01-03 | $276.26 | $193K | -4.2% | -4.8% | -17.3% |
| UTHR | SELL | 2022-12-01 | 2022-12-01 | $279.89 | $196K | +0.9% | -0.2% | -10.6% |
| UTHR | SELL | 2022-11-01 | 2022-11-02 | $230.28 | $161K | -0.1% | +9.2% | +3.2% |
| UTHR | SELL | 2022-10-03 | 2022-10-03 | $211.56 | $300K | -0.4% | +18.2% | +27.4% |
| UTHR | SELL | 2022-09-02 | 2022-09-06 | $225.98 | $2.2M | -1.3% | -5.0% | +23.9% |
| UTHR | SELL | 2022-05-26 | 2022-05-26 | $224.87 | $2.5M | +1.2% | +6.6% | -1.6% |
| EBS | SELL | 2020-09-02 | 2020-09-04 | $111.22 | $6.3M | -1.6% | +2.5% | -20.2% |
| EBS | SELL | 2020-03-04 | 2020-03-06 | $58.96 | $931K | +0.9% | +11.3% | +53.9% |
| EBS | SELL | 2016-05-12 | 2016-05-16 | $39.21 | $1.9M | +5.7% | +0.9% | -66.4% |
| EBS | SELL | 2016-05-11 | 2016-05-13 | $39.25 | $783K | +8.6% | +4.3% | -65.1% |
| EBS | SELL | 2016-03-11 | 2016-03-14 | $34.03 | $1.0M | +1.3% | +18.9% | +23.8% |
| EBS | SELL | 2016-03-10 | 2016-03-14 | $35.34 | $1.0M | +1.3% | +18.9% | +23.8% |
| HSIC | SELL | 2016-03-02 | 2016-03-03 | $168.59 | $4.0M | -0.3% | +2.4% | +2.9% |
| HSIC | SELL | 2015-11-17 | 2015-11-19 | $154.13 | $2.4M | -7.2% | -0.4% | +5.2% |
| UTHR | SELL | 2015-06-18 | 2015-06-22 | $185.60 | $2.8M | -11.9% | +0.8% | +0.8% |
| EBS | SELL | 2015-06-16 | 2015-06-17 | $31.33 | $422K | -12.7% | -2.9% | -2.9% |
| HSIC | SELL | 2014-08-29 | 2014-09-02 | $119.99 | $2.1M | -7.2% | -0.4% | -0.4% |
| UTHR | SELL · 10b5-1 | 2014-05-22 | 2014-05-23 | $101.46 | $3.0M | -11.9% | +0.8% | +0.8% |
| HSIC | SELL | 2014-05-13 | 2014-05-15 | $116.01 | $190K | -7.2% | -0.4% | -0.4% |
| UTHR | SELL | 2013-09-30 | 2013-10-01 | $78.48 | $3.3M | -11.9% | +0.8% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.